Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

Do SH2B3 rs3184504 CT and TNF rs1800629 AG weaken cytokine braking and increase inflammatory cytokine amplification?

SH2B3 rs3184504 CT and TNF rs1800629 AG can weaken cytokine regulation and increase susceptibility to inflammatory cytokine amplification.

PlausibleJuly 20, 202615 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

SH2B3 rs3184504 CT and TNF rs1800629 AG can weaken cytokine braking and increase susceptibility to inflammatory cytokine amplification.

laying out figure…
3 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes two genetic variants that may reduce normal immune feedback control. One is framed as weakening JAK-STAT inhibitory control, while the other is framed as increasing TNF-alpha production. Together, these changes are presented as favoring a more amplified inflammatory response.

Verified conclusion

Genetic variations in key regulatory genes can significantly alter the body's inflammatory baseline by disrupting molecular checkpoints and amplifying immune responses.

Mechanistic pathways of cytokine dysregulation

  • Impaired JAK-STAT inhibition: The SH2B3 rs3184504 CT genotype is a non-synonymous missense variant (R262W) in the pleckstrin homology domain of the LNK adaptor protein. This hypomorphic, partial loss-of-function mutation impairs LNK membrane localization and physical inhibition of JAK2, resulting in weakened regulatory control over downstream STAT4 and STAT5 phosphorylation.
  • Upregulated transcription: The TNF rs1800629 AG genotype features the high-producing -308A allele, which upregulates promoter-driven transcription of TNF-alpha by 2- to 8-fold compared to the ancestral GG genotype, leading to elevated mRNA and serum levels.

Susceptibility to inflammatory amplification

  • Cellular hyper-responsiveness: Due to compromised cellular braking, immune cells from SH2B3 risk-allele carriers display heightened sensitivity to cytokine signals (such as IL-2, IL-7, IL-12, and GM-CSF). Upon stimulation, CD8+ T cells exhibit elevated STAT4 phosphorylation and exaggerated interferon-gamma (IFN-γ) production.
  • Feed-forward inflammation: The high-producer TNF AG genotype generates elevated, sustained levels of TNF-alpha that can overpower or bypass endogenous negative feedback loops. This loss of homeostatic control fosters a pro-inflammatory environment characterized by expanded Th1-like T cell populations, myeloid cell activation, and elevated circulating levels of IL-1β, increasing susceptibility to chronic conditions like vascular inflammation and autoimmune disorders.

Bottom line

  • The SH2B3 rs3184504 CT genotype structurally compromises intracellular cytokine braking by disinhibiting the JAK-STAT pathway, while the TNF rs1800629 AG genotype drives high-yield TNF-alpha production. Collectively, these variants weaken immunological feedback loops and significantly increase susceptibility to inflammatory cytokine amplification.

References

  1. LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation — academic.oup.com ↗
  2. A Single Nucleotide Polymorphism in SH2B3/LNK Promotes Hypertension Development and Renal Damage — ahajournals.org ↗
  3. Abstract MP43: The Minor Allele Of A Single Nucleotide Polymorphism In SH2B3 Promotes Hypertension And Renal Dysfunction In Mice — ahajournals.org ↗
  4. The Autoimmune Risk R262W Variant of the Adaptor SH2B3 Improves Survival in Sepsis — journals.aai.org ↗
  5. SH2B3 — affinage.wi.mit.edu ↗
  6. Reduced function of the adaptor SH2B3 promotes T1D via altered gc cytokine-regulated, T cell intrinsic immune tolerance - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  7. The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms — pmc.ncbi.nlm.nih.gov ↗
  8. LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation. — academic.oup.com ↗
  9. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  10. Association study of a functional variant of TNF-α gene and ... — pubmed.ncbi.nlm.nih.gov ↗
  11. Tumor necrosis factor alpha gene variants do not display allelic imbalance in circulating myeloid cells — sciencedirect.com ↗
  12. 308 TNF promoter polymorphism on the transcriptional ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  13. Association of TNF-α-308 G>A (rs1800629) polymorphism with ... — pmc.ncbi.nlm.nih.gov ↗
  14. Tumor necrosis factor-α G-308A (rs1800629) polymorphism and aggressive periodontitis susceptibility: a meta-analysis of 16 case-control studies - Scientific Reports — nature.com ↗
  15. Reduced function of the adaptor SH2B3 promotes T1D via ... — biorxiv.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan hs-CRP reflect low-grade systemic inflammation even within the normal range?→Plausible8 sourcesCan rs1420101 CT, rs20541 AG, and rs1801275 AG contribute to type 2 eosinophilic airway inflammation susceptibility?→